Because the frequency of CD8 T cells specific for tumor antigen is higher in HNSCC patients (0.02–0.04%) than in healthy controls16, it is probable that HER-3-specific CD4 T cells are also increased in HNSCC patients. Here, CD4 is linked to neoplasm.